Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats
© Xu et al; licensee BioMed Central Ltd. 2009
Received: 09 December 2008
Accepted: 20 April 2009
Published: 20 April 2009
A complete explanation of the mechanisms by which Pb2+ exerts toxic effects on developmental central nervous system remains unknown. Glutamate is critical to the developing brain through various subtypes of ionotropic or metabotropic glutamate receptors (mGluRs). Ionotropic N-methyl-D-aspartate receptors have been considered as a principal target in lead-induced neurotoxicity. The relationship between mGluR3/mGluR7 and synaptic plasticity had been verified by many recent studies. The present study aimed to examine the role of mGluR3/mGluR7 in lead-induced neurotoxicity.
Twenty-four adult and female rats were randomly selected and placed on control or 0.2% lead acetate during gestation and lactation. Blood lead and hippocampal lead levels of pups were analyzed at weaning to evaluate the actual lead content at the end of the exposure. Impairments of short -term memory and long-term memory of pups were assessed by tests using Morris water maze and by detection of hippocampal ultrastructural alterations on electron microscopy. The impact of lead exposure on mGluR3 and mGluR7 mRNA expression in hippocampal tissue of pups were investigated by quantitative real-time polymerase chain reaction and its potential role in lead neurotoxicity were discussed.
Lead levels of blood and hippocampi in the lead-exposed rats were significantly higher than those in the controls (P < 0.001). In tests using Morris Water Maze, the overall decrease in goal latency and swimming distance was taken to indicate that controls had shorter latencies and distance than lead-exposed rats (P = 0.001 and P < 0.001 by repeated-measures analysis of variance). On transmission electron microscopy neuronal ultrastructural alterations were observed and the results of real-time polymerase chain reaction showed that exposure to 0.2% lead acetate did not substantially change gene expression of mGluR3 and mGluR7 mRNA compared with controls.
Exposure to lead before and after birth can damage short-term and long-term memory ability of young rats and hippocampal ultrastructure. However, the current study does not provide evidence that the expression of rat hippocampal mGluR3 and mGluR7 can be altered by systemic administration of lead during gestation and lactation, which are informative for the field of lead-induced developmental neurotoxicity noting that it seems not to be worthwhile to include mGluR3 and mGluR7 in future studies.
In spite of extensive documentation of the toxic effects of Pb2+ on human health, a complete and detailed explanation of the mechanisms by which Pb2+ exerts its effects on the central nervous system has not yet been found. Numerous studies have shown [1–3] that prenatal and early postnatal exposure to lead results in a long-term potentiation (LTP) decrease, cognitive deficits, and behavioral problems.
Interference with the glutamatergic neurotransmitter system has proved to be one of the key mechanisms that explains neurotoxicity of lead . Glutamate is the major excitatory neurotransmitter in the mammalian brain and it mediates activity-dependent processes critical to both the developing and mature brain [4–6]. Glutamate exerts its effects through various subtypes of ionotropic or metabotropic (mGluRs) receptors . Activation of the ionotropic N-methyl-D-aspartate receptors (NMDARs) plays a central role in brain development and learning and memory, which have been considered as principal consequences of lead-induced neurotoxicity [4, 8–10]. However, little is known about whether mGluRs are involved in lead neurotoxicity.
mGluRs have recently been extensively studied. mGluRs are composed of eight isoforms (mGluR1~8) which are classified into groups I, II, and III. Group II (mGluR2 and mGluR3) and group III (mGluR4, mGluR6, and mGluR7) receptors are negatively coupled to adenylate cyclase by Go and possibly Gi protein [11, 12]. Previous studies have shown that antagonists and agonists of mGluRs can modulate the induction, formation, and maintenance of LTP [11–15], a form of neuronal plasticity that is involved in memory and learning. The mGluR3 receptors are localized at high densities in brain areas associated with cognition and memory, such as the hippocampus, cortex and olfactory bulb [16–18]. Expression of mGluR7 is relatively high on CA3 neurons in the CA1 region . The relationship between mGluR3/mGluR7 and synaptic plasticity had been verified by many recent studies. Pharmacological activation of mGluR3 revealed that mGluR3 may be of marked significance in the regulation of excitability in neuronal networks, as well as of synaptic plasticity [20–23]. In the study by Pöschel et al , activation of postsynaptic mGluR3 receptors were found necessary for long-term depression (LTD), presynaptic mGluR3 receptors functioned as modulators of both LTP and LTD . On the other hand, the presynaptic axons of CA3 pyramidal neurons primarily express mGluR7, and mGluR7 modulate synaptic transmission at a variety of central synapses [24–26]. For example, Bushell et al.  reported that the initial decremental phase of LTP, known as short-term potentiation, was greatly attenuated in the mGluR7 knockout mouse (mGluR7-/-), which suggested a role for mGluR7 in short-term potentiation in the CA1 region.
We therefore undertook this study to examine the possible role of mGluR3 and mGluR7 in lead neurotoxicity. We used a whole-animal model and real-time polymerase chain reaction (PCR) to analyze the expression of mGluR3 and mGluR7 in the hippocampus of developmental rats exposed to lead during the pre- and postnatal periods. We wish to ascertain the impact of lead exposure on mGluR3 and mGluR7 expression and their potential roles in lead neurotoxicity.
Animal protocol and Pb2+ exposure
Rats were exposed to Pb2+ during development as previously described [9, 27]. Briefly, twenty-four adult Sprague-Dawley rats were individually housed in plastic cages with bedding at 22 ± 2°C under a 12-hour light: dark cycle (male-female ratio 2:1, weight 200~250 g). Eight female rats were randomly selected and placed on control or 0.2% lead acetate water (Sigma-Aldrich, St. Louis, MO) from 10 days prior to mating and until postnatal day 21, namely gestational and lactational lead exposure. The lead-exposed group (4 litters) and control group (4 litters) both received the same treatment throughout the study and food and water were provided ad libitum. One day after parturition, litters were culled to 8 pups (male-female ratio 1:1) and the pups were weaned at 21 days of age. After weaning, all pups were fed deionized drinking water. All procedures complied with institutional guidelines regarding the ethical care and use of animals.
Blood lead and hippocampal lead analysis
In each litter, four weaning pups including 2 male and 2 female rats were randomly selected to analyze the blood lead and hippocampal lead levels to evaluate the actual lead content at the end of the exposure. Blood samples (0.3–0.5 ml) were collected by cardiac puncture in tubes containing EDTA-disodium. Blood lead levels were determined via Thermo Elemental Solaar M6 Series (Thermo Elemental, Franklin, MA, USA) by Graphite Furnace Atomic Absorption Spectrometry and the quality control procedure for the assessment of lead exposure was performed. Hippocampus from both left and right sides were collected from each rat, rinsed softly with saline, sopped up water with filter paper, pooled together as one sample and weighed. After hippocampal tissues were digested by nitric acid and hydrogen peroxide, they were heated in the microwave digestion oven (CEM MARS5, USA). After that, hippocampal lead levels were measured by inductively coupled plasma mass spectrometry (ICP-MS, Agilent 7500 CE, Agilent Technologies, USA). The operations are all performed in our ICP-MS lab, which meets the Chinese Standard (GBJ173-1984) and provides air to meet class 100 (class I) conditions.
Ultrastructural details of hippocampus were studied with electron microscopy as described [9, 28]. Briefly, after 32 weaning rats (8 litters, 4 pups/litter) were sampled by cardiac puncture as above, they were immediately decapitated and collected from both sides of hippocampi and immediately cut into tissue blocks (1 mm × 1 mm × 5 mm) and were processed for electron microscopy. Ultrathin sections (50 nm) were cut with an ultramicrotome (Ultracut, Reichert-Jung) and stained with 4% uranyl acetate for 20 minutes and with 1% Pb for 10 minutes prior to examination by electron microscopy (H-500, HITACHI, Japan). The slides were read by a designated and experienced pathologist who was blinded to the dose groups.
Morris water maze (MWM)
A test using the MWM was performed when young rats were 30 days old. In each litter, only one male and one female pups were randomly selected. The MWM was originally designed by English psychologist Morris in the 1980s , which consisted of a dark circular pool 150 cm in diameter and 50 cm in height. The pool was filled to a height of 35 cm with water at 22°C ± 0.5°C stained by black ink. A transparent Plexiglas® escape platform (12 cm in diameter) 5 cm below the water surface and invisible to the rats was located in the center of the southwest quadrant. The room had numerous extramaze cues that remained constant throughout the experiment and no intramaze cues to ensure that the rats had to rely on the location of extramaze cues to locate the platform. The procedure included a training portion and test portion. Each training day consisted of 4 trials per animal, with a quasi-randomly selected release location from each compass point (N, E, S, W). On trial 1 of day 1, the animal was released from the appropriate starting location and once the rat located the platform it was allowed to stay on it for 10 seconds. If the rat did not find the platform within 120 seconds, it was guided to reach it and allowed to remain on it for 10 seconds and then was returned to its heated cage following completion of the task. Twenty-four hours after last training trial (postnatal day (PND) 35), 7 days later (PND 42), and 1 month later (PND72), spatial memory was repeatedly examined. On each occasion experimental procedures and surroundings were kept constant. The time required to reach the platform (escape latency), distance swimming to the platform, and the swimming speed as well as the time and distance spent in each quadrant were recorded by a video tracking system. The measures were averaged per rat within each daily session.
The MWM originally was aimed to test short-term memory (STM), namely spatial reference memory. In previous studies, the retention tests including the inhibitory avoidance task , hippocampal dependent discrimination task , and conditioned taste aversion , were performed to examine long-term memory (LTM) of rats which were conducted at 5 days , 7 days  or 1 month  after training. However, there have not any studies to assess the MWM test for evaluation of LTM. In this study, we tried to modify the classic MWM procedure and add our self-designed retention test, which might be a new and practical way to apply the MWM to evaluate LTM.
Total RNA isolation
At 21 days of age, both sides of hippocampus of pups (8 litters, one male and one female pups/litter) were harvested and stored frozen at -80°C prepared for PCR. RNA was isolated using a Trizol kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Extracted RNA concentrations and purity were evaluated by measuring the A260 nm-to-A280 nm absorbance ratio with an ultraviolet spectrophotometer (Perkin Elmer, Wellesley, MA, USA). Integrity of RNA was assessed by agarose gel electrophoresis.
Real-time reverse transcription (RT)-PCR
Highly purified oligonucleotide primers were commercially generated (SBS Genetech, China). Primer design and optimization were performed with Oligo software (National Biosciences Inc., Plymouth, MN, USA) . The primers used were the following: mGluR3 [GenBank: M92076], sense 5'-GAC GTG GTC CTG GTG ATC CTA T-3', antisense 5'-CTA ACG GAG ATG CAC ATT G-3', 197 bp; mGluR7 [GenBank: D16817], sense 5'-CCA GAC AAC AAA CAC AAC CAACC-3', antisense 5'-GCG TTC CCT TCT GTG TCT TCT TC-3', 173 bp; β-actin, sense 5'-AGA CCT CTA TGC CAA CAC AGT GCT G-3', and antisense 5'-TCA TCG TAC TCC TGC TTG CTG A-3', 218 bp.
One-step, real-time quantitative RT-PCR was carried out with a LightCycler instrument (Roche, Mannheim, Germany) by using the LightCycler SYBR Green I RNA Master Kit (Roche, Mannheim, Germany). All reactions were conducted in duplicate. Negative control was performed with sterile purified deionized water. Each cycle of PCR included denaturation at 95°C for 5 seconds, primers annealing at 62°C for 5 seconds, and a final extension at 72°C for 12 seconds. The fluorescence of each sample was measured at 5°C below the melting temperatures (Tms) to eliminate background fluorescence due to primer-dimer . Results were analyzed with LightCycler Software version 3.5 by using the second derivative maximum method to set the CT. E was calculated using the equation E = 10(-1/slope) [36–38]. Agarose gel electrophoresis analyses were also performed to verify whether the amplified product corresponded to the size predicted for gene-specific product.
Relative quantification was carried out with the Relative Expression Software Tool (REST, Roche, Mannheim, Germany). Because the expression level of the β-actin gene was constant regardless of lead exposure , relative qualification was presented by means of normalization with the β-actin gene. Relative and normalized expression ratios (R) were calculated on the basis of the median of the performed duplicates and computed according to the following equation: R = Etargetexp(ΔCTtarget)/Erefexp(ΔCTref) [29, 36, 37].
Wilcoxon test was used in the analyses . The variations in mGluR3 and mGluR7 expression were compared using coefficients of variability and the Wilcoxon two group test. Blood lead levels and hippocampal lead levels were analyzed with one-way analysis of variance (ANOVA). In the MWM task, distance traveled (cm) and escape latency were the principal measures to evaluate the performance of the rats during acquisition training. The baselines of pretraining latency and swimming distance of two groups were analyzed with one-way ANOVA. Because the experimental design involves both a between-subjects factor (lead dose condition) and a within-subjects factor (days), repeated measures ANOVA was performed. Data are presented as mean ± SD and the level of significance is P < 0.05 (two tailed). All statistical evaluations were performed using standard statistical software (SAS Institute Inc., Cary, NC, USA).
Blood lead and hippocampal lead analysis
Lead concentrations of blood and hippocampus were 3.0 ± 0.2 μg/dL and 51.9 ± 6.5 μg/kg, respectively, in 16 control rats and 56.8 ± 4.4 μg/dL and 432.9 ± 15.1 μg/kg, respectively, in 16 lead-exposed rats. Lead levels of blood and hippocampi in the rats exposed to lead were significantly higher than those in the controls (n = 16, P < 0.001).
Neuronal ultrastructural alterations
Spatial learning and memory abilities evaluated by MWM
Expression levels of mGluR3 and mGluR7 mRNA after lead exposure
Optical-density ratios at 260 to 280 nm for total RNA were all between 1.8 and 2.0. Agarose gel electrophoresis showed that the 28S and 18S ribosomal RNA bands were clearly visible at a staining intensity of about 2:1 (28S:18S).
Our study has assessed the impact of lead exposure during the gestational and lactational periods on gene expression of mGluR3 and mGluR7 mRNA, but significant difference of expression levels is not observed in lead-exposed rats and non-exposed controls.
In this study, lead exposure level of 0.2% lead acetate was administered to Sprague-Dawley rats as was used in most lead-exposed experiments, which was found to cause an increase in rats' blood lead levels similar to the degree of modest to severe lead poisoning in children. Thus we considered that the dose of lead exposure which has been used in this study was appropriate and the hypothesis that the exposure level of 0.2% lead acetate might be too low to reveal any obvious change in expression of mGluR3 and mGluR7 mRNA should be ruled out.
On the other hand, the putative role of G-protein-coupled metabotropic receptors in LTP and LTD has been the subject of intense investigation recently. Although recent studies demonstrated that mGluR3 played an essential role in LTD and a modulatory role in LTP, and functioned to regulate activity-dependent synaptic potentiation in the hippocampus [21, 41], and mGluR7 might mediate a reduction in synaptic transmission through a mechanism such as decreasing calcium influx [19, 24], the results of our studies showed that no obvious variation of mGluR3/7 mRNA expression occurred after pre-natal and early post-natal lead exposure. Many studies have revealed that ionotropic glutamate receptors NMDARs acted as one of targets of lead induced neurotoxicity, mainly by means of the decreased expression of NMDARs subtypes NR2A mRNA and NR1 mRNA and therefore resulting in a decrease of calcium-dependent synaptic transmission. There is still lack of studies of other factors, such as the studies of effects of lead exposure on affinity of glutamate receptors. Several scientists had done some research about the impact of lead on binding abilities of glutamate receptors and found that developmental lead exposure altered expression levels of components of NMDAR with no change in binding affinity [42, 43]. The binding affinity was not considered as key elements of lead induced neurotoxicity [44, 45]. In conclusion, we speculate that rat mGluR3 and mGluR7 might not involve in the pathways mediating lead neurotoxicity. A potential limitation of the present study is that the results are only from rats and lack of data of other genus yet.
In neuronal ultrastructural detection and MWM task, we found that exposure to lead before and after birth can result in ultrastructural alterations and STM deficits, which is consistent with previous results [44, 45]. The hippocampus called "time window of memory" plays an especially important role in the storage of STM and the transition from STM to LTM [46–49], hippocampal ultrastructural alterations maybe one of mechanisms of lead-induced neurotoxicity. Moreover, a modified MWM procedure was applied and LTM was found also injured which was another proof that lead may cause irreversible neurological damage to neurodevelopment.
The present study suggests that lead exposure has no obvious effect on hippocampal mGluR3 and mGluR7 mRNA expression, and rat hippocampal mGluR3 and mGluR7 might not associate with lead induced neurotoxicity. Further studies are required to reveal the outcomes of another spliced variants of mGluRs after lead exposure. We believe this study is among the first to examine the role of mGluR3 and mGluR7 in lead neurotoxicity.
Funds for this research came from National Natural Science Foundation of China (30070665), Shanghai Key Laboratory of Children's Environmental Health (08DZ2271200, 06DZ22024), and agency of 2007 thesis prize plan for education, social science and medical research.
- Hu H, Téllez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, Schwartz J, Schnaas L, Mercado-García A, Hernández-Avila M: Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect. 2006, 114: 1730-1735.PubMed CentralPubMed
- Schnaas L, Rothenberg SJ, Flores MF, Martinez S, Hernandez C, Osorio E, Velasco SR, Perroni E: Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect. 2006, 114: 791-797.PubMed CentralView ArticlePubMed
- Wasserman GA, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, LoIacono N, Graziano JH: The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol. 2000, 22: 811-818. 10.1016/S0892-0362(00)00106-9.View ArticlePubMed
- Guilarte TR: Glutamatergic system and developmental lead neurotoxicity. Neurotoxicology. 1997, 18: 665-672.PubMed
- Schlett K: Glutamate as a modulator of embryonic and adult neurogenesis. Curr Top Med Chem. 2006, 6: 949-960. 10.2174/156802606777323665.View ArticlePubMed
- White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC, Basha MR: New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol. 2007, 225: 1-27. 10.1016/j.taap.2007.08.001.View ArticlePubMed
- Ozawa S, Kamiya H, Tsuzuki K: Glutamate receptors in the mammalian central nervous system. Prog Neurobiol. 1998, 54: 581-618. 10.1016/S0301-0082(97)00085-3.View ArticlePubMed
- Bressler J, Kim KA, Chakraborti T, Goldstein G: Molecular mechanisms of lead neurotoxicity. Neurochem Res. 1999, 24: 595-600. 10.1023/A:1022596115897.View ArticlePubMed
- Nihei MK, Desmond NL, McGlothan JL, Kuhlmann AC, Guilarte TR: N-methyl-D-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neurosci. 2000, 99: 233-242. 10.1016/S0306-4522(00)00192-5.View Article
- Nihei MK, Guilarte TR: Molecular changes in glutamatergic synapses induced by Pb2+: association with deficits in LTP and spatial learning. Neurotoxicology. 2001, 22: 635-643. 10.1016/S0161-813X(01)00035-3.View ArticlePubMed
- Grassi S, Frondaroli A, Pettorossi VE: Different metabotropic glutamate receptors play opposite roles in synaptic plasticity of the rat medial vestibular nuclei. J Physiol. 2002, 543: 795-806. 10.1113/jphysiol.2002.023424.PubMed CentralView ArticlePubMed
- Schwartz NE, Alford S: Physiological activation of presynaptic metabotropic glutamate receptors increases intracellular calcium and glutamate release. J Neurophysiol. 2000, 84: 415-427.PubMed
- Bortolotto ZA, Bashir ZI, Davies CH, Taira T, Kaila K, Collingridge GL: Studies on the role of metabotropic glutamate receptors in long-term potentiation: some methodological considerations. J Neurosci Methods. 1995, 59: 19-24. 10.1016/0165-0270(94)00189-N.View ArticlePubMed
- Lapointe V, Morin F, Ratte S, Croce A, Conquet F, Lacaille JC: Synapse-specific mGluR1-dependent long-term potentiation in interneurones regulates mouse hippocampal inhibition. J Physiol. 2004, 555: 125-135. 10.1113/jphysiol.2003.053603.PubMed CentralView ArticlePubMed
- Sato T, Tanaka K, Ohnishi Y, Teramoto T, Irifune M, Nishikawa T: Inhibitory effects of group II mGluR-related drugs on memory performance in mice. Physiol Behav. 2004, 80: 747-758. 10.1016/j.physbeh.2003.12.010.View ArticlePubMed
- Mudo G, Trovato-Salinaro A, Caniglia G, Cheng Q, Condorelli DF: Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain. Brain Res. 2007, 1149: 1-13. 10.1016/j.brainres.2007.02.041.View ArticlePubMed
- Shimazaki T, Kaku A, Chaki S: Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats. Eur J Pharmacol. 2007, 575: 94-97. 10.1016/j.ejphar.2007.08.006.View ArticlePubMed
- Tamaru Y, Nomura S, Mizuno N, Shigemoto R: Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience. 2001, 106: 481-503. 10.1016/S0306-4522(01)00305-0.View ArticlePubMed
- Manahan-Vaughan D, Reymann KG: Regional and developmental profile of modulation of hippocampal synaptic transmission and LTP by AP4-sensitive mGluRs in vivo. Neuropharmacology. 1995, 34: 991-1001. 10.1016/0028-3908(95)00081-G.View ArticlePubMed
- Kamiya H, Shinozaki H, Yamamoto C: Activation of metabotropic glutamate receptor type 2/3 suppresses transmission at rat hippocampal mossy fibre synapses. J Physiol. 1996, 493: 447-455.PubMed CentralView ArticlePubMed
- Lea PM, Wroblewska B, Sarvey JM, Neale JH: Beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor. J Neurophysiol. 2001, 85: 1097-1106.PubMed
- Pöschel B, Wroblewska B, Heinemann U, Manahan-Vaughan D: The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats. Cereb Cortex. 2005, 15: 1414-1423. 10.1093/cercor/bhi022.View ArticlePubMed
- Pöschel B, Manahan-Vaughan D: Group II mGluR-induced long term depression in the dentate gyrus in vivo is NMDA receptor-independent and does not require protein synthesis. Neuropharmacology. 2005, 49: 1-12. 10.1016/j.neuropharm.2005.06.018.View ArticlePubMed
- Bushell TJ, Sansig G, Collett VJ, Putten van der H, Collingridge GL: Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7. Scientific World Journal. 2002, 2: 730-737.View ArticlePubMed
- Goddyn H, Callaerts-Vegh Z, Stroobants S, Dirikx T, Vansteenwegen D, Hermans D, Putten van der H, D'Hooge R: Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice. Neurobiol Learn Mem. 2008, 90: 103-111. 10.1016/j.nlm.2008.01.001.View ArticlePubMed
- Pelkey KA, Lavezzari G, Racca C, Roche KW, McBain CJ: MGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition. Neuron. 2005, 46: 89-102. 10.1016/j.neuron.2005.02.011.View ArticlePubMed
- Gilbert ME, Lasley SM: Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus in vivo. Neurotoxicol Teratol. 2007, 29: 385-393. 10.1016/j.ntt.2007.01.006.View ArticlePubMed
- Zhou L, Welsh AM, Chen D, Koliatsos VE: NMDA inhibitors cause apoptosis of pyramidal neurons in mature piriform cortex: evidence for a nitric oxide-mediated effect involving inhibitory interneurons. Neuropharmacology. 2007, 52: 1528-1537. 10.1016/j.neuropharm.2007.02.013.PubMed CentralView ArticlePubMed
- Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000, 25: 169-193. 10.1677/jme.0.0250169.View ArticlePubMed
- Morris RG, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature. 1982, 297: 681-683. 10.1038/297681a0.View ArticlePubMed
- Pereira P, Ardenghi P, de Souza MM, Choi H, Moletta B, Izquierdo I: Effects of infusions of the tyrosine kinase inhibitor radicicol into the hippocampus on short- and long-term memory of the inhibitory avoidance task. Behav Pharmacol. 2001, 12: 299-302.View ArticlePubMed
- Vázquez A, Peña de, Ortiz S: Lead (Pb(+2)) impairs long-term memory and blocks learning-induced increases in hippocampal protein kinase C activity. Toxicol Appl Pharmacol. 2004, 200: 27-39. 10.1016/j.taap.2004.03.011.View ArticlePubMed
- Wang J, Ren K, Pérez J, Silva AJ, Peña de, Ortiz S: The antimetabolite ara-CTP blocks long-term memory of conditioned taste aversion. Learn Mem. 2003, 10: 503-509. 10.1101/lm.63003.PubMed CentralView ArticlePubMed
- Machhor N, Balaji T, Raju TN: Postnatal dexamethasone and long term learning and memory functions in developing rats: Effect of postnatal age and gender. Life Sci. 2004, 74: 1925-1935. 10.1016/j.lfs.2003.09.044.View ArticlePubMed
- Wu MW, Xian LJ, Li XM, Pasquale I, Francis L: Circadian expression of dihydropyrimidine dehydrogenase, thymidylate synthase, c-myc and p53 mRNA in mouse liver tissue. Ai Zheng. 2004, 23: 235-242.PubMed
- Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29: e45-10.1093/nar/29.9.e45.PubMed CentralView ArticlePubMed
- Pfaffl MW, Horgan GW, Dempfle L: Relative Expression Software Tool (REST©) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30: e36-10.1093/nar/30.9.e36.PubMed CentralView ArticlePubMed
- Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D, Agay D, Chancerelle Y, Multon E: Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 2004, 5: 3-10.1186/1471-2172-5-3.PubMed CentralView ArticlePubMed
- Zawia NH, Harry GJ: Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol Appl Pharmacol. 1996, 138: 43-47. 10.1006/taap.1996.0095.View ArticlePubMed
- Yuan JS, Reed A, Chen F, Stewart CN: Statistical analysis of real-time PCR data. BMC Bioinformatics. 2006, 7: 85-10.1186/1471-2105-7-85.PubMed CentralView ArticlePubMed
- Bergeron R, Coyle JT, Tsai G, Greene RW: NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology. 2005, 30: 7-16. 10.1038/sj.npp.1300559.View ArticlePubMed
- Toscano CD, Hashemzadeh-Gargari H, McGlothan JL, Guilarte TR: Developmental Pb exposure alters NMDAR subtypes and reduces CREB phosphorylation in the rat brain. Brain Res Dev Brain Res. 2002, 139: 217-226. 10.1016/S0165-3806(02)00569-2.View ArticlePubMed
- Guilarte TR, McGlothanm JL: Selective decrease in NR1 subunit splice variant mRNA in the hippocampus of Pb-exposed rats: implications for synaptic targeting and cell surface expression of NMDAR complexes. Brain Res Mol Brain Res. 2003, 113: 37-43. 10.1016/S0169-328X(03)00083-4.View ArticlePubMed
- Toscano CD, Guilarte TR: Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev. 2005, 49: 529-554. 10.1016/j.brainresrev.2005.02.004.View ArticlePubMed
- Lidsky TI, Schneider JS: Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain. 2003, 126: 5-19. 10.1093/brain/awg014.View ArticlePubMed
- Izquierdo I, Medina JH, Izquierdo LA, Barros DM, de Souza MM, Souza TM: Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiol Learn Mem. 1998, 69: 219-224. 10.1006/nlme.1998.3825.View ArticlePubMed
- Fernandez-Espejo E: Basic neurobiology of hippocampal formation. Rev Neurol. 1996, 24: 779-784.PubMed
- Redish AD, Touretzky DS: The role of the hippocampus in solving the Morris Water Maze. Neural Computation. 1998, 10: 73-111. 10.1162/089976698300017908.View ArticlePubMed
- Lee I, Kesner RP: Time-dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory. J Neurosci. 2003, 23: 1517-1523.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.